Simplex Trading
CNTA

Simplex Trading’s Centessa Pharmaceuticals CNTA Stock Holding History

Simplex Trading’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
+38,700
New +$990K ﹤0.01% 2062
2025
Q4 		– Sell
-9,800
Closed -$237K – 8738
2025
Q3 		$237K Buy
9,800
+4,600
+88% +$81.8K ﹤0.01% 4729
2025
Q2 		$68K Buy
5,200
+4,700
+940% +$59.5K ﹤0.01% 5604
2025
Q1 		$7K Buy
+500
New +$8.18K ﹤0.01% 7302
2024
Q4 		– Sell
-100
Closed -$1K – 8636
2024
Q3 		$1K Sell
100
-1,100
-92% -$13.5K ﹤0.01% 8157
2024
Q2 		$10K Sell
1,200
-300
-20% -$2.85K ﹤0.01% 7405
2024
Q1 		$16K Buy
1,500
+1,000
+200% +$9.47K ﹤0.01% 7249
2023
Q4 		$3K Buy
500
+200
+67% +$1.34K ﹤0.01% 8059
2023
Q3 		$1K Buy
+300
New +$2.05K ﹤0.01% 8271

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Simplex Trading's CNTA Position: Q4 2025 in Review

Simplex Trading sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 2,622 shares — an estimated $63K sold.

Simplex Trading first reported a position in CNTA in Q3 2022 and held it in 5 quarters. The position peaked at $63K in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

  • Simplex Trading reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 2,622 Centessa Pharmaceuticals shares in Q4 2025, an estimated $63K.
  • Simplex Trading first reported a position in Centessa Pharmaceuticals in Q3 2022 and held it in 5 quarters.
  • Simplex Trading's Centessa Pharmaceuticals position peaked at $63K in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.